Luminor Medical Technologies Inc. (LMT.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,483,000 | 3,151,000 | 2,523,000 | 2,790,000 | 1,442,000 |
| Receivables | 15,308,000 | 16,365,000 | 16,837,000 | 16,307,000 | 15,315,000 |
| Inventories | 3,474,000 | 3,234,000 | 3,097,000 | 3,278,000 | 3,132,000 |
| Other current assets | 584,000 | 461,000 | 510,000 | 583,000 | 632,000 |
| TOTAL | $21,849,000 | $23,211,000 | $22,967,000 | $22,958,000 | $20,521,000 |
| Non-Current Assets | |||||
| PPE Net | 8,726,000 | 8,454,000 | 8,394,000 | 8,354,000 | 8,370,000 |
| Intangibles | 13,082,000 | 12,779,000 | 12,827,000 | 12,940,000 | 13,011,000 |
| Other Non-Current Assets | 11,960,000 | 11,076,000 | 10,888,000 | 10,711,000 | 10,554,000 |
| TOTAL | $33,768,000 | $32,309,000 | $32,109,000 | $32,005,000 | $31,935,000 |
| Total Assets | $55,617,000 | $55,520,000 | $55,076,000 | $54,963,000 | $52,456,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 643,000 | 142,000 | 142,000 | 168,000 | 168,000 |
| Accounts payable and accrued liabilities | 2,222,000 | 3,221,000 | 3,282,000 | 3,523,000 | 2,312,000 |
| Accrued Expenses | 3,125,000 | 3,076,000 | 2,871,000 | 2,679,000 | 3,133,000 |
| Other current liabilities | 3,635,000 | 2,320,000 | 3,017,000 | 2,584,000 | 2,134,000 |
| TOTAL | $19,420,000 | $17,810,000 | $18,493,000 | $17,699,000 | $16,937,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,627,000 | 19,179,000 | 19,115,000 | 19,250,000 | 17,291,000 |
| Deferred Revenues | 9,795,000 | 9,051,000 | 9,181,000 | 8,745,000 | 9,190,000 |
| Other Non-Current Liabilities | 10,237,000 | 11,331,000 | 11,293,000 | 11,364,000 | 11,393,000 |
| TOTAL | $29,864,000 | $30,510,000 | $30,408,000 | $30,614,000 | $28,684,000 |
| Total Liabilities | $49,284,000 | $48,320,000 | $48,901,000 | $48,313,000 | $45,621,000 |
| Shareholders' Equity | |||||
| Common Shares | 234,000 | 236,000 | 237,000 | 239,000 | 240,000 |
| Retained earnings | 14,551,000 | 15,657,000 | 14,707,000 | 15,222,000 | 15,398,000 |
| Other shareholders' equity | -8,452,000 | -8,693,000 | -8,769,000 | -8,811,000 | -8,803,000 |
| TOTAL | $6,333,000 | $7,200,000 | $6,175,000 | $6,650,000 | $6,835,000 |
| Total Liabilities And Equity | $55,617,000 | $55,520,000 | $55,076,000 | $54,963,000 | $52,456,000 |